Roles of Randomized Controlled Trials in Establishing Evidence-Based Gender-Affirming Care and Advancing Health Equity
Dados Bibliográficos
| ID | 15744937 |
|---|---|
| Autores | Theodore E Schall (0000-0002-0353-2657, Department of Health, autor correspondente), Kenneth Jaffe (0000-0002-5084-4100, Department of Health), Jacob D Moses (0000-0001-8089-3870, The University of Texas Medical Branch at Galveston) |
| Ano | 2024 |
| Volume | 26 |
| Fascículo | 9 |
| Páginas | E684-689 |
| Data de publicação | 2024-09-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | The AMA Journal of Ethic (JOURNAL) |
| Identificadores do periódico | ISSN: 2376-6980 • E-ISSN: 2376-6980 |
| Editora | American Medical Association (PUBLISHER • US) |
| DOI | 10.1001/amajethics.2024.684 |
| PMID | 39250939 |
| OpenAlex | W4402299076 |
| Idioma | EN |
| Citações recebidas | 1 |
This article reviews the design of a recently published randomized controlled trial (RCT) on immediate vs delayed access to gender-affirming hormones for transgender and gender-diverse (TGD) people and outlines key learning points that clinicians should know about how RCTs can and cannot contribute to advancing health equity for TGD people
Economic growth · Economics · Equity (law · Health care · Health equity · Political science · Public health · Randomized controlled trial · Diversity and Career in Medicine · Medicine · Nursing · Primary Care and Health Outcomes · Psychology · Sex and Gender in Healthcare · Internal Medicine
| Obras citantes distintas | 1 |
|---|---|
| Citações por ano | 1 |
| Intervalo de citações | 2025 - 2025 (1) |
| Velocidade de citação | recent |
| Altamente citado | Não |
| Tipos de citação | Neutras: 1 |